Ultrastructural changes in the rat kidney after single dose of cyclophosphamide-Possible roles for peroxisome proliferation and lysosomal dysfunction in cyclophosphamide-induced renal damage

Human and Experimental Toxicology

Volumn 30, Issue 12, 2011, Pages 1924-1930

  Abraham, Premila ^a   Isaac, Bina ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Cyclophosphamide; Kidney; Lysosomes; Mitochondria; Peroxisome proliferation; Rats

Indexed keywords

CYCLOPHOSPHAMIDE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL DAMAGE; CELL DEATH; CELL DESTRUCTION; CELL ELONGATION; CELL ORGANELLE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EXPOSURE; ENDOPLASMIC RETICULUM; ENDOTHELIUM; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GRANULAR CELL; KIDNEY; KIDNEY INJURY; KIDNEY STRUCTURE; KIDNEY TUBULE; KIDNEY TUBULE EPITHELIUM; LYSOSOME; MALE; MITOCHONDRION; NONHUMAN; PEROXISOME; PODOCYTE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES; LYSOSOMES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NECROSIS; ORGANELLES; PEROXISOMES; RATS; RATS, WISTAR;

RATTUS;

EID: 84855829944     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111402240     Document Type: Article

References (38)

1. Reiter A, Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. Br J Haematol 2008; 142: 329-347. (Pubitemid 351962165)
2. Palumbo A and Rajkumar SV. Multiple myeloma: chemotherapy or transplantation in the era of new drugs. Eur J Haematol 2010; 84: 379-390.
3. Laurenti L, De Padua L, Tarnani M, et al. Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukemia: influence of biological parameters on the clinical outcome. Ann Hematol 2010; Jul 13. [Epub ahead of print].
4. Appelbaum FR. Optimising the conditioning regimen for acute myeloid leukemia. Best Pract Res Clin Haematol 2009; 22: 543-550.
5. McArthur HL and Hudis CA. Dose-dense therapy in the treatment of early-stage breast cancer: an overview of the data. Clin Breast Cancer 2007; 8 Suppl 1: S6-S10. (Pubitemid 351204449)
6. Tungsinmunkong K, Chandeying N, Hanprasertpong J, Hanprasertpong T, Thammavichit T, and Kongkabpan D. Primary non-Hodgkin's lymphoma of the uterine cervix. Asian Pac J Cancer Prev 2008; 9: 363-366.
7. Pirker R, Berzinec P, Brincat S, et al. Therapy of small cell lung cancer with emphasis on oral topotecan. Lung Cancer 2010; Jun 23 [Epub ahead of print].
8. Watanabe Y, Etoh T, Koike E, Mizuno Y, Wang WM, and Hoshiai H. Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer. Int J Clin Oncol 2010; 15: 468-471.
9. KimJH, Lee SJ, Bae JH, et al. Adjuvant therapy in highrisk early endometrial carcinoma: a retrospective analysis of 46 cases. J Gynecol Oncol 2008; 19: 236-240.
10. Treon SP. How I treat Waldenström macroglobulinemia. Blood 2009; 114: 2375-2385.
11. Dadarkar SS, Fonseca LC, Mishra PB, et al. Phenotypic and genotypic assessment of concomitant druginduced toxic effects in liver, kidney and blood. J Appl Toxicol 2010; Jul 9.
12. Feng C, Tang SQ, Wang JW, Liu Y, and Yang G. [Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma] [Article in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi 2009; 11: 885-887.
13. Kopecna L. Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia. Bratisl Lek Listy 2001; 102: 357-360.
14. Pérez-Suárez G, Raya JM, Alvarez A, et al. Progressive renal failure as the first manifestation of monoclonal light-chain deposition disease with rapid multiple organ involvement. Clin Nephrol 2009; 71: 314-317.
15. Beyzadeoglu M, Arpaci F, Surenkok S, et al. Acute renal toxicity of 2 conditioning regimens in patients undergoing autologous peripheral blood stem-cell transplantation. Total body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide. Saudi Med J 2008; 29: 832-836.
16. Koren G, Chen N, and Aleksa K. Drug-induced nephrotoxicity in children: pharmacologically based prevention of long-term impairment. Paediatr Drugs 2007; 9: 139-142. (Pubitemid 46849132)
17. Zinzani PL. Salvage chemotherapy in follicular non-Hodgkin's lymphoma: focus on tolerability. Clin Lymphoma Myeloma 2006; 7: 115-124. (Pubitemid 44603869)
18. Stankiewicz A and Skrzydlewska E. Protection against cyclophosphamide- induced renal oxidative stress by amifostine: the role of antioxidative mechanisms. Toxicol Mech Methods 2003; 13: 301-308. (Pubitemid 37462926)
19. Abraham P and Sugumar E. Enhanced PON1 activity in the kidneys of cyclophosphamide treated rats may play a protective role as an antioxidant against cyclophosphamide induced oxidative stress. Arch Toxicol 2008; 82: 237-238. (Pubitemid 351661648)
20. Abraham P and Suganthy R. Nitrosative stress, protein tyrosine nitration, PARP activation and NAD depletion in the kidneys of rats after single dose of cyclophosphamide. Clin Exp Nephrol 2009; 13: 281-287.
21. Abraham P, Indirani K, and Sugumar E. Effect of cyclophosphamide treatment on selected lysosomal enzymes in the kidney of rats. Exp Toxicol Pathol 2007; 59: 143-149. (Pubitemid 47405228)
22. Lavin P and Koss LG. Effects of a single dose of cyclophosphamide on various organs of in the rat. IV. Electron microscopic study of the renal tubules. Am J Pathol 1970; 62: 169-175.
23. Boveris A, Oshino N, and Chance B. The cellular production of hydrogen peroxide. Biochem J 1972; 128: 617-630.
24. Fahimi HD, Reinicke A, Sujatta M, Yokota S, and Ozel M. The short-and long-term effects of bezafibrate in the rat. Ann N Y Acad Sci 1982; 386: 111-135. (Pubitemid 12036589)
25. Nemali MR, Usuda N, Reddy MK, et al. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res 1988; 48: 5316-5324.
26. Reddy JK, Goel SK, Nemali MR, et al. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc Natl Acad Sci U S A 1986; 83: 1747-1751. (Pubitemid 16018640)
27. Nemali MR, Reddy MK, Usuda N, et al. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Toxicol Appl Pharmacol 1989; 97: 72-87. (Pubitemid 19054594)
28. Rao MS and Reddy JK. Hepatocarcinogenesis of peroxisome proliferators. AnnNYAcad Sci 1996; 804: 573-587. (Pubitemid 27056640)
29. Rao MS and Reddy JK. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis 1987; 8: 631-636. (Pubitemid 17122522)
30. Kasai H, Okada Y, Nishimura S, Rao MS, and Reddy JK. Formation of 8-hydroxy deoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res 1989; 49: 2603-2605. (Pubitemid 19143385)
31. Reddy JK, Lalwani ND, Reddy MK, and Qureshi SA. Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cancer Res 1982; 42: 259-266. (Pubitemid 12207276)
32. Liu B and Preisig PA. Renal hypertrophy following uninephrectomy (Unx) is associated with activation of cdk2/cyclin E, but not cdk4/cyclinD1 kinase (abstract). J Am Soc Nephrol 1997; 8: 424.
33. Ernster L and Schatz G. Mitochondria: a historical review. J Cell Biol 1981; 91: 227s-255s. (Pubitemid 12177871)
34. Schrader M and Yoon Y. Mitochondria and peroxisomes: are the 'big brother' and the 'little sister' closer than assumed? Bioessays 2007; 29: 1105-1114.
35. Neuspiel M, Schauss AC, Braschi E, et al. Cargoselected transport from the mitochondria to peroxisomesis mediated by vesicular carriers. Curr Biol 2008; 18: 102-108.
36. Gartner LP and Hiatt JL. Cytoplasm. In: Color Textbook of Histology. 2nd ed. WB Saunders Company, Pennsylvania, 2001, p.11-49.
37. Csala M, Banhegyi G, and Benedetti A. Endoplasmic reticulum: a metabolic compartment. FEBS Lett 2006; 580: 2160-2165.
38. Sato S, Dai W, Liu XL, and Asano G. The protective effect of hepatocyte growth-promoting factor (pHGF) against carbon tetrachloride-induced acute liver injury in rats: an ultrastructural study. Med Electron Microsc 1999; 32: 184-192. (Pubitemid 30182207)